source
- GSK prepares for patent cliff with $2.5B cost-cutting planThe pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.
- Six key issues we’re watching at Fauci’s hearingSen. Rand Paul is forcing Fauci to appear before his Senate panel.